Personal Finance on Yik Yak | Found a new biotech company that seems like a potential easy 50% depending on how sales fair. $TNXP Just got approval on a fibromyalgia drug. Expected revenue between $219 mil to $365 mil in 2026. Market cap is only $332.8 million right now.

Yik Yak

Download

Join communities on Yik Yak Download

Personal Finance 4w

Found a new biotech company that seems like a potential easy 50% depending on how sales fair. $TNXP Just got approval on a fibromyalgia drug. Expected revenue between $219 mil to $365 mil in 2026. Market cap is only $332.8 million right now.

-1

Anonymous 4w

They have a substantial cash runway for launch which is one of my biggest concerns when looking to invest in a biotech company post-approval of a product. Don’t see any reason to fear dilution or taking on excessive debt to support the launch.

Anonymous 4w

Analysts predict peak revenue potential of $800 mil to $950 mil.

Anonymous 4w

Anonymous 4w

Why did someone downvote this

Anonymous

#1 3w

Because it’s biotech (high risk industry) and a lot of people feel very strongly about only investing in index funds.